Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
ÇÑÀºÁø, ¼ÛÇϵµ, ¾çÁöÈÆ, ¹Ú¼Ò¿µ, ±è¼ºÈÆ, À±Çö±¸, ÀÓâÈÆ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÇÑÀºÁø ( Han Eun-Jin )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
¼ÛÇϵµ ( Song Ha-Do )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
¾çÁöÈÆ ( Yang Ji-Hoon )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
¹Ú¼Ò¿µ ( Park So-Young )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
±è¼ºÈÆ ( Kim Sung-Hoon )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
À±Çö±¸ ( Yoon Hyun-Koo )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
ÀÓâÈÆ ( Yim Chang-Hoon )
Kwandong University College of Medicine Cheil General Hospital Department of Internal Medicine
KMID : 0356620130280030221
Abstract
Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones. Recently, we found that the long-acting GnRH agonist aggravated hyperthyroidism and induced painless thyroiditis. This is the first report to demonstrate the association of thyroid dysfunction with GnRH agonist injection in Korea. Here, we report three cases and emphasize the clinical importance of this aggravating factor in autoimmune thyroid disease.
Å°¿öµå
Gonadotropin-releasing hormone agonist; Graves¡¯ disease; Painless thyroiditis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸